Susquehanna International Group, LLP Adamis Pharmaceuticals Corp Put Options Transaction History

Susquehanna International Group, LLP

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$0.34 - $0.57 $3,774 - $6,326	-11,100 Reduced 42.21%	15,200 $8,000
Q1 2022 May 16, 2022	SELL	$0.55 - $0.73 $37,070 - $49,202	-67,400 Reduced 71.93%	26,300 $15,000
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.23 $118,103 - $254,856	-207,200 Reduced 68.86%	93,700 $57,000
Q3 2021 Nov 15, 2021	SELL	$0.92 - $1.18 $208,288 - $267,152	-226,400 Reduced 42.94%	300,900 $292,000
Q2 2021 Aug 11, 2021	SELL	$0.66 - $1.23 $58,278 - $108,609	-88,300 Reduced 14.34%	527,300 $580,000
Q1 2021 May 17, 2021	BUY	$0.54 - $1.79 $324,486 - $1.08 Million	600,900 Added 4087.76%	615,600 $579,000
Q3 2019 Nov 14, 2019	SELL	$0.7 - $1.46 $47,040 - $98,112	-67,200 Reduced 82.05%	14,700 $10,000
Q2 2019 Aug 14, 2019	SELL	$1.26 - $2.23 $72,324 - $128,002	-57,400 Reduced 41.21%	81,900 $106,000
Q1 2019 May 15, 2019	SELL	$2.02 - $3.22 $112,716 - $179,676	-55,800 Reduced 28.6%	139,300 $294,000
Q4 2018 Feb 14, 2019	SELL	$2.1 - $3.21 $477,120 - $729,312	-227,200 Reduced 53.8%	195,100 $439,000
Q3 2018 Nov 14, 2018	BUY	$2.25 - $4.8 $803,475 - $1.71 Million	357,100 Added 547.7%	422,300 $1.48 Million
Q2 2018 Aug 14, 2018	BUY	$3.2 - $4.7 $5,440 - $7,990	1,700 Added 2.68%	65,200 $209,000
Q1 2018 May 15, 2018	SELL	$2.55 - $4.85 $72,930 - $138,710	-28,600 Reduced 31.05%	63,500 $222,000
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $46,900 - $75,710	13,400 Added 17.03%	92,100 $405,000
Q3 2017 Nov 14, 2017	BUY	$4.5 - $5.65 $354,150 - $444,655	78,700	78,700 $411,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.